1 min read
Clinical research in Saudi Arabia continues to expand, bringing greater emphasis on inspection readiness and Good Clinical Practice (GCP) compliance. For sponsors, CROs, and investigators, understanding what SFDA inspectors look for can help minimize findings, protect study participants, and maintain the integrity of clinical trial data.
What Are SFDA Clinical Trial Inspections?
SFDA clinical trial inspections are regulatory assessments conducted to verify that studies are performed in accordance with approved protocols, ethical standards, and GCP requirements. These inspections may take place before, during, or after a clinical trial and are designed to ensure participant safety and data reliability.
What Are GCP Inspectors Looking For?
Recent analyses of SFDA inspection findings highlight several recurring areas of focus:
1. Informed Consent Compliance
Inspectors review whether participants provided informed consent before undergoing any study-related procedures. Missing signatures, incorrect dates, use of outdated consent forms, and inadequate documentation remain common observations.
2. Protocol Adherence
Protocol deviations receive close scrutiny. Sponsors and sites should demonstrate that deviations are identified promptly, documented appropriately, investigated, and corrective actions implemented.
3. Data Integrity and Documentation
SFDA follows a data-focused inspection approach, reviewing source documents, case report forms, and essential records to confirm accuracy, completeness, and consistency.
4. Investigational Product Accountability
Auditors assess how investigational products are received, stored, dispensed, returned, and reconciled throughout the study lifecycle.
5. Training and Oversight
Staff qualifications, GCP training records, delegation logs, and evidence of sponsor oversight are routinely reviewed. Training should be current and aligned with assigned responsibilities.
How to Prepare for an SFDA Inspection
Inspection readiness should be built into daily trial operations rather than treated as a last-minute activity.
- Conduct periodic internal GCP audits and gap assessments.
- Review informed consent files for completeness and accuracy.
- Maintain contemporaneous and inspection-ready documentation.
- Monitor and address protocol deviations proactively.
- Reconcile investigational product records regularly.
- Ensure staff training and delegation logs remain up to date.
Organizations that adopt a proactive quality culture are often better equipped to navigate inspections with confidence and reduce the risk of significant findings.
Build Inspection Readiness Early
SFDA inspections are more than compliance exercises; they demonstrate an organization's commitment to participant safety, ethical conduct, and data integrity.
Freyr supports sponsors, CROs, and clinical sites with GCP gap assessments, inspection readiness programs, audit support, and Regulatory guidance to help teams prepare SFDA inspections with confidence.